Filing Details

Accession Number:
0001079973-22-001315
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-11 17:21:08
Reporting Period:
2022-09-29
Accepted Time:
2022-10-11 17:21:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1128189 Protokinetix Inc. PKTX Pharmaceutical Preparations (2834) 943355026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516077 Edward Clarence Smith 1409 Peachtree Road
Daytona Beach FL 32114
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-29 3,333,333 $0.03 37,594,443 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,235,160 Indirect See footnote
Common Stock 1,850,000 Indirect See footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $0.06 2030-03-14 4,750,000 4,750,000 Direct
Common Stock Stock Option $0.11 2028-08-03 25,000,000 25,000,000 Direct
Common Stock Stock Option $0.11 2028-08-03 2,600,000 2,600,000 Direct
Common Stock Warrant $0.05 2022-03-30 2024-03-15 600,000 600,000 Direct
Common Stock Warrant $0.05 2022-03-18 2024-03-15 1,000,000 1,000,000 Direct
Common Stock Warrant $0.12 2019-12-19 2022-12-18 216,666 216,666 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2030-03-14 4,750,000 4,750,000 Direct
2028-08-03 25,000,000 25,000,000 Direct
2028-08-03 2,600,000 2,600,000 Direct
2024-03-15 600,000 600,000 Direct
2024-03-15 1,000,000 1,000,000 Direct
2022-12-18 216,666 216,666 Direct
Footnotes
  1. Shares purchased as part of a private placement with the Company.
  2. Shares held by the Clarence E. Smith Trusts.
  3. Shares held by Mr. Smith's retirement account.
  4. Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on March 15, 2022. On March 31, 2022, 1,187,500 shares vest; thereafter 1,187,500 shares vest each quarter.
  5. Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. Fully vested.
  6. Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. On September 30, 2021, 650,000 shares vest; thereafter 650,000 shares vest each quarter.